The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
39 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The Leukemia & Lymphoma Society, Inc. (LLS) is a healthcare company that offers blood cancer researches and funds raising services. The companys services include patient services, health education, policy advocacy, funds raising and medical research funding. It offers treatments for the diseases such as leukemia, lymphoma, hodgkin disease and myeloma. LLS advance at the diagnosis and treatement of blood cancers by funding academic research, therapy acceleration program and other specialized initiatives. The company has its presence in the US and Canada. LLS is headquartered in White Plains, New York, the US

The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on majo

  
Source:
Document ID
GDPH188102D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
The Leukemia &Lymphoma Society, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
The Leukemia &Lymphoma Society, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
The Leukemia &Lymphoma Society, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
The Leukemia &Lymphoma Society, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
The Leukemia &Lymphoma Society, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
The Leukemia &Lymphoma Society, Inc., Pharmaceuticals &Healthcare, Deal Details1125
  Venture Financing111
    OncoPep Raises USD7 Million in Series B Venture Financing111
  Partnerships121
    Kite Pharma Enters into Agreement with Leukemia &Lymphoma Society121
    Evotec Enters Into Research Agreement With Leukemia &Lymphoma Society131
    Stemline Therapeutics Enters Into Co-Development Agreement With Leukemia &Lymphoma Society142
    Leukemia &Lymphoma Society Terminates its Agreement with Onconova Therapeutics161
    Constellation Pharma Enters Into Agreement With Leukemia &Lymphoma Society To Develop BET Inhibitors Drugs For Hematologic Cancers172
    The Leukemia &Lymphoma Society Enters Into Co-Development Agreement With Celator Pharma For CPX-351192
    Curis Enters Into Co-Development Agreement With The Leukemia &Lymphoma Society212
    Leukemia &Lymphoma Society Enters Into An Agreement With EpiZyme232
    Acetylon Pharma Enters Into Co-Development Agreement With Leukemia &Lymphoma Society252
    Ascenta Therapeutics Enters Into Co-Development Agreement With The Leukemia &Lymphoma Society271
    The Leukemia &Lymphoma Society Enters Into An Agreement With BioTheryX281
    The Leukemia &Lymphoma Society Enters Into An Agreement With Shape Pharma291
    Avila Therapeutics Enters Into Co-Development Agreement With The Leukemia &Lymphoma Society301
    Leukemia &Lymphoma Enters Into Drug Discovery Agreement With FORMA Therapeutics311
  Equity Offering321
    Kiadis Pharma Raises USD0.8 Million in Second Tranche of Private Placement of Shares322
    Kiadis Pharma Raises USD1 Million in Private Placement of Shares342
The Leukemia &Lymphoma Society, Inc. - Key Competitors361
Key Employees371
Locations And Subsidiaries381
  Head Office381
Appendix391
  Methodology391
  About GlobalData391
  Contact Us391
  Disclaimer391

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Leukemia-Lymphoma-Society-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-16075>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The Leukemia & Lymphoma Society, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Leukemia-Lymphoma-Society-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-16075>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research